Core Insights - Eos Energy Enterprises, Inc. reported a net loss attributable to shareholders of $969.6 million for the fourth quarter and full year 2025, primarily due to $746.8 million or 77% in non-cash items related to fair value accounting, capital structure optimization, and other factors such as stock-based compensation and depreciation [1] Company Performance - The significant net loss reported by Eos Energy indicates potential compliance issues with federal securities laws, prompting an investigation by Holzer & Holzer, LLC [1] - Following the announcement of the financial results, the stock price of Eos Energy experienced a decline [1]

ATLANTA, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Camping World Holdings, Inc. (“Camping World” or the “Company”) (NYSE: CWH) complied with federal securities laws. On February 24, 2026, Camping World announced its fourth quarter 2025 results, including a full year net loss of $105.6 million, which the Company said was “driven largely by adjustments to deferred tax assets and the tax receivable agreement liability.” Camping World also announced it was pausing its cash ...

ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Ardent Health, Inc. (ARDT) The shareholder class action lawsuit filed against Ardent Health, Inc. (“Ardent Health” or the “Company”) (NYSE: ARDT) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding the collectability of Ardent Health’s accounts receivable betwe ...

ATLANTA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Driven Brands Holdings, Inc. (“Driven” or the “Company”) (NASDAQ: DRVN) complied with federal securities laws. On February 25, 2026, Driven announced it would be restating certain previously issued financial results after determining those reports contained material errors. The price of the Driven’s stock dropped following the announcement. If you purchased Driven stock and suffered a loss on that investment, you are en ...

ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Zynex, Inc. (“Zynex” or the “Company”) (OTCMKTS: ZYXIQ). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding Zynex’s business, operations, and prospects, including allegations that: (1) Zynex shipped products, including electrodes, in excess of need; (2) as a result of this practice, the Company inflated its revenue; and (3) th ...

ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ: LAKE). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding Lakeland’s business, operations, and prospects, including allegations that: (1)  Lakeland was experiencing significant, sustained issues with its Pacific Helmets and Jolly businesses, including, inter alia ...

Core Points - A shareholder class action lawsuit has been filed against Navan, Inc. alleging false and misleading statements regarding the company's business and operations [1] - The lawsuit specifically highlights that Navan increased its "sales and marketing" expenses by 39% for the quarter ending October 31, 2025, coinciding with its initial public offering [1] Legal Information - Investors who purchased Navan shares during the October 31, 2025 IPO and suffered significant losses are encouraged to discuss their legal rights with the law firm Holzer & Holzer [2] - The deadline to request lead plaintiff status in the lawsuit is April 24, 2026 [3]

ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding Inovio’s business, operations, and prospects, including allegations that: (i) manufacturing for Inovio’s CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit the INO-3107 Biologi ...

ATLANTA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against REGENXBIO Inc. (NASDAQ: RGNX). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts concerning the efficacy and safety of its RGX-111 trial study, causing Plaintiff and other shareholders to purchase REGENXBIO’s securities at artificially inflated prices. If you purchased REGENXBIO shares between February 9, 2022 and January 27, 2026, an ...

ATLANTA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding uniQure’s business, operations, and prospects, including allegations that: (1) the design of uniQure’s Pivotal Study—including comparison of the Pivotal Study results to the ENROLL-HD external historical data set—was no ...